Contact this trialFirst, we need to learn more about you.
Anti-tumor antibiotic
Ixazomib + Gemcitabine + Doxorubicin for Bladder Cancer
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial is testing a combination of drugs to treat urothelial cancer. Ixazomib citrate, gemcitabine hydrochloride, and doxorubicin hydrochloride will be given to see what side effects occur and what the best dose is.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service